Results 11 to 20 of about 2,520 (168)

Vestibular Evoked Myogenic Potentials to Diagnose Vestibular Neuritis: A Scoping Review. [PDF]

Laryngoscope
Standardization of stimulation and recording protocols is essential to improve comparability across VEMP studies. Integrating cervical and ocular VEMPs with other vestibular tests enhances diagnostic accuracy and supports precise localization of vestibular neuritis.
Piatti D, Conti LC, Paolocci G, Indovina I, Tramontano M, Manzari L.   +5 more
europepmc   +2 more sources

The Epidemiology and Clinical Presentation of the Acute Imbalance Syndrome (AIS)-A Systematic Review and Meta-Analysis. [PDF]

Eur J Neurol
ABSTRACT Objectives The acute imbalance syndrome (AIS) refers to acute‐onset and persistent vertigo, dizziness and/or imbalance without nystagmus, reflecting a subset of the acute vestibular syndrome (AVS) with or without nystagmus. While AVS with nystagmus is well characterized and the approach to these patients is validated, much less is known about ...
Schmidt K, Zwergal A, Kaski D, Tarnutzer AA.   +3 more
europepmc   +2 more sources

Acute vestibular neuritis may provoke atrial fibrillation

Internal Medicine Journal, Volume 53, Issue 8, Page 1429-1434, August 2023., 2023
Abstract Background Exclusion of stroke is the focus of guidelines in the emergency department assessment of acute vertigo, especially with new‐onset atrial fibrillation (AF). Early diagnosis of vestibular neuritis (VN) is also important but may be deferred awaiting brain magnetic resonance imaging (MRI) for exclusion of stroke.
Adam G. Mirabelli, Ronald Dick, Bernard Infeld, Richard P. Gerraty   +3 more
wiley   +1 more source

The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis

Journal of Viral Hepatitis, Volume 30, Issue 5, Page 448-454, May 2023., 2023
Abstract To evaluate the safety and tolerability of the fixed‐dose, single‐tablet regimen sofosbuvir/velpatasvir (SOF/VEL) for the treatment of hepatitis C virus (HCV) infection in three Phase 3 studies in patients with and without compensated cirrhosis.
Ira M. Jacobson, Stefan Bourgeois, Phillipe Mathurin, Paul Thuluvath, Stephen D. Ryder, Guido Gerken, Candido Hernandez, Kim Vanstraelen, Stacey Scherbakovsky, Anu Osinusi, Dana Tedesco, Graham R. Foster   +11 more
wiley   +1 more source

Measuring benefit from non‐surgical interventions in otolaryngology for different conditions, using the revised 5‐factor Glasgow Benefit Inventory

Clinical Otolaryngology, Volume 48, Issue 1, Page 25-31, January 2023., 2023
Abstract Objectives The Glasgow Benefit Inventory (GBI) has been extensively used to report the benefit from otolaryngological surgery. Benefit from non‐surgical management has not been reported, despite this being the outcome of most otolaryngology and audiology consultations.
Haytham Kubba, William M. Whitmer, George G. Browning   +2 more
wiley   +1 more source

Otologic and vestibular symptoms in COVID‐19: A scoping review

World Journal of Otorhinolaryngology - Head and Neck Surgery, Volume 8, Issue 4, Page 287-296, December 2022., 2022
Abstract Background Otologic and vestibular symptoms have been seen in patients confirmed to have COVID‐19 disease. Further discussion of these symptoms may provide insight into short‐ and long‐term management for these patients. Objective The aim of this review was to describe the otologic and vestibular symptoms that present in patients with COVID‐19.
Kimberly Mae C. Ong, Teresa Luisa G. Cruz   +1 more
wiley   +1 more source

Corticosteroids in patients with vestibular neuritis: An updated meta‐analysis

Acta Neurologica Scandinavica, Volume 146, Issue 5, Page 429-439, November 2022., 2022
Vestibular neuritis is a common neuro‐otological entity. Therapeutically, corticosteroids are advised, although the evidence is limited. The objective of this review is to update meta‐analyses of clinical trials that address the question of whether patients with vestibular neuritis treated with corticosteroids show better recovery than control patients.
Anna Bogdanova, Julia Dlugaiczyk, Josef Georg Heckmann, Stefan Schwab   +3 more
wiley   +1 more source

U.S. Emergency Department Visits for Dizziness and Vertigo From 2016 to 2022. [PDF]

Acad Emerg Med
Academic Emergency Medicine, Volume 33, Issue 1, January 2026.
Miulli MM, Kim HS.
europepmc   +2 more sources

Vertigo‐Associated Vomiting

JPGN Reports, Volume 3, Issue 3, August 2022., 2022
Thiamine deficiency can manifest as Wernicke encephalopathy, with the classic clinical triad of altered mental status, nystagmus, and ataxia. Although a rare diagnosis in pediatric patients within developed countries, gastrointestinal disorders that impair nutritional intake and absorption can place patients at higher risk.
Xiaoyi Zhang, Vincent Arnone, Kimberly Ackerman, Feras Al‐issa   +3 more
wiley   +1 more source

A specialized approach to diagnosing and treating vertigo

Неврология, нейропсихиатрия, психосоматика, 2016
Vertigo is one of the most common reasons for visits to physicians of different specialties. Thorough collection of history data and neurovestibular examination by a set of simple clinical tests are of great importance for the diagnosis of diseases of ...
L. M. Antonenko, V. A. Parfenov
doaj   +1 more source